These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15678642)

  • 1. Preventing warfarin-related bleeding.
    Glasheen JJ
    South Med J; 2005 Jan; 98(1):96-103. PubMed ID: 15678642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematology consult: high-sensitivity warfarin genotype.
    Schwer C; Lamana S; Dasanu CA
    Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes.
    Rubin TA; Murdoch M; Nelson DB
    Gastrointest Endosc; 2003 Sep; 58(3):369-73. PubMed ID: 14528210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
    Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
    Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
    Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.
    Shalansky S; Lynd L; Richardson K; Ingaszewski A; Kerr C
    Pharmacotherapy; 2007 Sep; 27(9):1237-47. PubMed ID: 17723077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.
    Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D
    Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
    Hylek EM
    Semin Vasc Med; 2003 Aug; 3(3):271-8. PubMed ID: 15199460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current issues in the initial phase of warfarin therapy].
    Squizzato A; Steidl L; Ageno W
    Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical liability risk avoidance: a case for adopting the International Normalized Ratio (INR) system.
    Kline SS; Atkins MO
    Am J Manag Care; 1997 Jan; 3(1):59-63. PubMed ID: 10169250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.